Pillstats
Rx only · Tablet, Film Coated · Oral

Imatinib Mesylate

Imatinib Mesylate

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US27 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers13 labelers
Packages40
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.565$1.13$1.69$2.26Dec 2025Mar 2026Jun 2026
$1.765
Latest avg · Jun 17, 2026
-8%
Since Dec 17, 2025
13
Active US suppliers
40%
Top-2 supplier share*

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Apotex Corp.unknown10SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown6SUPPLYING
BluePoint Laboratoriesunknown4SUPPLYING
Aurobindo Pharma Limitedunknown3SUPPLYING
Major Pharmaceuticalsunknown2SUPPLYING
Quallent Pharmaceuticals Health LLCunknown2SUPPLYING
Camber Pharmaceuticals, Inc.unknown2SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown2SUPPLYING
Armas Pharmaceuticals Inc.unknown2SUPPLYING
CivicaScript LLCunknown2SUPPLYING
Chartwell RX, LLCunknown2SUPPLYING
Ascend Laboratories, LLCunknown2SUPPLYING
American Health Packagingunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.